InvestorsHub Logo
icon url

another_voice_2

06/10/13 9:28 PM

#68756 RE: another_voice_2 #68736

No one took a crack at answering either question.
Good news! 2 questions we need to answer.
actually more than2, but..
1. What time will all alan release their opion on this news? It will give us more of a lift.
2. Did NNVC find the consultant Cote, or did they see an opportunity and call NNVC? Yes, it makes a difference!
icon url

Doctor_Hari_Seldon

06/11/13 6:34 PM

#68777 RE: another_voice_2 #68736

The orphan app is quite a nice piece. If the status is granted, it will certainly generate interest.

Regarding 2, yes it makes a difference. However, seeing that he is probably the most leading authority on FDA orphan drug initatives and a champion of them, having him agree to do the app is a big plus. Big plus.

I certainly hope they get it, it would be a game changer. If the PRV would come, that is a wammy game changer. Instant returns.

As we approach 60 days. I will twitch a little.

Was the 50% survival rate in the lethal mouse model expressed previously well? That is truly impressive.

HS